[go: up one dir, main page]

ATE265450T1 - Magnesiumomeprazol - Google Patents

Magnesiumomeprazol

Info

Publication number
ATE265450T1
ATE265450T1 AT00952815T AT00952815T ATE265450T1 AT E265450 T1 ATE265450 T1 AT E265450T1 AT 00952815 T AT00952815 T AT 00952815T AT 00952815 T AT00952815 T AT 00952815T AT E265450 T1 ATE265450 T1 AT E265450T1
Authority
AT
Austria
Prior art keywords
magnesiumomeprazole
methanol
pharmaceutically acceptable
low level
pharmaceutical compositions
Prior art date
Application number
AT00952815T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4164727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE265450(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE265450T1 publication Critical patent/ATE265450T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Electroplating Methods And Accessories (AREA)
  • Conductive Materials (AREA)
  • Contacts (AREA)
AT00952815T 1999-11-16 2000-08-04 Magnesiumomeprazol ATE265450T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002290893A CA2290893C (en) 1999-11-16 1999-11-16 Magnesium omeprazole
PCT/CA2000/000901 WO2001036409A1 (en) 1999-11-16 2000-08-04 Magnesium omeprazole

Publications (1)

Publication Number Publication Date
ATE265450T1 true ATE265450T1 (de) 2004-05-15

Family

ID=4164727

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952815T ATE265450T1 (de) 1999-11-16 2000-08-04 Magnesiumomeprazol

Country Status (8)

Country Link
US (1) US6713495B1 (de)
EP (1) EP1230237B2 (de)
JP (2) JP3971187B2 (de)
AT (1) ATE265450T1 (de)
AU (1) AU782651B2 (de)
CA (1) CA2290893C (de)
DE (1) DE60010316T3 (de)
WO (1) WO2001036409A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
CA2409258A1 (en) * 2000-05-15 2001-11-22 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts
CA2386716C (en) * 2002-05-17 2012-07-24 Bernard Charles Sherman Magnesium salt of s-omeprazole
US6894066B2 (en) * 2002-05-09 2005-05-17 Bernard Charles Sherman Magnesium salt of S-omeprazole
WO2004020436A1 (en) * 2002-08-30 2004-03-11 Reddy's Laboratories Limited Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof
AU2003273000A1 (en) * 2002-10-16 2004-05-04 Takeda Pharmaceutical Company Limited Stable solid preparations
EP1556043A1 (de) * 2002-10-22 2005-07-27 Ranbaxy Laboratories, Ltd. Amorphe form von esomeprazol-magnesiumsalz
EP1583507A2 (de) * 2003-01-07 2005-10-12 Ranbaxy Laboratories Limited Magnesiumsalz eines imidazol-derivats
CA2516600C (en) 2003-03-24 2011-04-05 Eisai Co., Ltd. Process for production of sulfoxide proton pump inhibitors in the amorphous state
EP1827429A4 (de) * 2004-12-20 2009-08-05 Reddys Lab Ltd Dr Pharmatzeutische zusammensetzungen mit amorphen benzimidazolverbindungen
US8658216B2 (en) 2004-12-23 2014-02-25 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
WO2006087613A2 (en) * 2005-02-02 2006-08-24 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions prepared by non-aqueous layering process
EP1856101A4 (de) * 2005-03-08 2009-10-21 Reddys Lab Ltd Dr Verfahren zur herstellung von amorphen salzen
EP1801110A1 (de) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Argininsalz des Esomeprazols
US7553857B2 (en) * 2005-12-23 2009-06-30 Lek Pharmaceuticals D.D. S-omeprazole magnesium
EP1947099A1 (de) * 2007-01-18 2008-07-23 LEK Pharmaceuticals D.D. Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
US8911787B2 (en) 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP2147918A1 (de) 2008-07-21 2010-01-27 LEK Pharmaceuticals D.D. Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
DE69522921T2 (de) 1994-07-08 2002-04-11 Astrazeneca Ab Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)
JPH08134101A (ja) * 1994-11-15 1996-05-28 Daicel Chem Ind Ltd 粉粒状セルロースエステルの製造方法
SE508669C2 (sv) 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
US6048981A (en) 1998-04-22 2000-04-11 Torcan Chemical Ltd. Magnesium omeprazole and process for its preparation
SE9804003D0 (sv) 1998-11-23 1998-11-23 Astra Ab A method of producing drug particles
CA2290893C (en) * 1999-11-16 2007-05-01 Bernard Charles Sherman Magnesium omeprazole
CA2409258A1 (en) * 2000-05-15 2001-11-22 Ranbaxy Laboratories Limited Novel amorphous form of omeprazole salts

Also Published As

Publication number Publication date
CA2290893C (en) 2007-05-01
EP1230237A1 (de) 2002-08-14
JP2007126485A (ja) 2007-05-24
DE60010316T2 (de) 2005-05-04
EP1230237B2 (de) 2011-07-20
DE60010316D1 (de) 2004-06-03
US6713495B1 (en) 2004-03-30
EP1230237B1 (de) 2004-04-28
AU782651B2 (en) 2005-08-18
WO2001036409A1 (en) 2001-05-25
AU6551100A (en) 2001-05-30
DE60010316T3 (de) 2012-01-26
JP2003514813A (ja) 2003-04-22
JP3971187B2 (ja) 2007-09-05
CA2290893A1 (en) 2001-05-16

Similar Documents

Publication Publication Date Title
ATE265450T1 (de) Magnesiumomeprazol
LU92381I2 (fr) Macitentan et ses dérivés pharmaceutiquement acceptables (OPSUMIT)
LU92024I2 (fr) Pasireotide et ses dérivés pharmaceutiquement acceptables (SIGNIFOR)
NO20031019L (no) Vedvarende frigivelsesformuleringer av oksymorfon
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
JO2282B1 (en) Oxazole derivatives
GB9917408D0 (en) Compounds
AU2001263229A1 (en) Compositions and methods for administration of pharmacologically active compounds
TR200103493T2 (tr) Metaloproteaz önleyicileri
BR112012007412A2 (pt) tabletes transformáveis de forma oral.
MY135683A (en) Compositions for improving fertility
IT1301966B1 (it) Composizioni farmaceutiche ad attivita' analgesica
AR021934A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
NO20024598D0 (no) Farmasöytisk aktive pyrrolidinderivater
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
SE0003476D0 (sv) Compounds
DK1150704T3 (da) Melagatran til behandling af betændelse
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
IS6919A (is) Stöðug lyfjablanda sem felur í sér torsemíð afbrigði II
BR0208655A (pt) Composição farmacêuticas
AR026243A1 (es) Solucion oral de galantamina
PT1181300E (pt) Derivados 6-o-carbamato de cetolido
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties